ADORA3

Adenosine receptor A3 · P0DMS8 · ADORA3 on Sugi Atlas →

717,381 patent compounds predicted against ADORA3, 486,744 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Nifedipine Nifedipine (SCHEMBL3968) 1.00 7/20
1-Methylxanthine 1-Methylxanthine (SCHEMBL10996) 0.64 7/20
SCHEMBL3541 SCHEMBL3541 0.56 6/20
SCHEMBL8565 SCHEMBL8565 0.40 6/20
Atrimustine Atrimustine (SCHEMBL8659) 0.56 5/20
Xanthine Xanthine (SCHEMBL4965) 0.41 5/20
Adenosine Adenosine (SCHEMBL731) 1.00 4/20
Miconazole Miconazole (SCHEMBL2866) 1.00 4/20
(R)-Miconazole (R)-Miconazole (SCHEMBL2867) 1.00 4/20
Clocortolone Pivalate Clocortolone Pivalate (SCHEMBL5120) 1.00 4/20
Prochlorperazine Prochlorperazine (SCHEMBL18429) 1.00 4/20
Miconazole Miconazole (SCHEMBL3366) 0.98 4/20
(R)-Miconazole (R)-Miconazole (SCHEMBL3367) 0.98 4/20
Vidarabine Vidarabine (SCHEMBL2929) 0.97 4/20
Theophylline Anhydrous Theophylline Anhydrous (SCHEMBL4915) 0.96 4/20
Estramustine Phosphate Estramustine Phosphate (SCHEMBL19436) 0.86 4/20
Miconazole Miconazole (SCHEMBL15799) 0.84 4/20
(R)-Miconazole (R)-Miconazole (SCHEMBL15800) 0.84 4/20
Theophylline Anhydrous Theophylline Anhydrous (SCHEMBL5037) 0.81 4/20
Fludarabine Fludarabine (SCHEMBL4105) 0.67 4/20

Clinical trials — most relevant to ADORA3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Stress Testing and Cardiac Magnetic Resonance PHASE4COMPLETED
Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia PHASE4COMPLETED
Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D) PHASE4COMPLETED
Ticagrelor in Remote Ischemic Preconditioning Study PHASE4COMPLETED
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI PHASE4RECRUITING
Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease PHASE2/PHASE3COMPLETED
Preventing Acute Kidney Injury (AKI) in Pediatric Patients PHASE3UNKNOWN
Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode PHASE3COMPLETED
Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy PHASE3COMPLETED
PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function PHASE3COMPLETED
PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function PHASE3COMPLETED
Clonidine Versus Adenosine to Treat Neuropathic Pain PHASE2COMPLETED
Psychopharmacology for Cocaine Dependence - Buspirone PHASE2COMPLETED
KW-6002 to Treat Parkinson's Disease PHASE2COMPLETED
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation PHASE1UNKNOWN
Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers PHASE1COMPLETED
Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444 PHASE1COMPLETED
Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System EARLY_PHASE1COMPLETED
Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient EARLY_PHASE1UNKNOWN
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity nanRECRUITING
Adenosine and A2A Receptors in Human Brown Adipose Tissue nanCOMPLETED
Polymorphisms, Caffeine and Sleep Disorders nanCOMPLETED
Poor Sleep and Inflammation in HIV-Infected Adults nanCOMPLETED
Determination of Coronarphysiological Parameters With the Method of Thermodillution nanCOMPLETED
Pilot Study on Caffeine Efficiency in ADCY5-related Dyskinesia nanCOMPLETED
Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia nanCOMPLETED
Genetic Causes of Panic Disorder nanCOMPLETED
Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia nanRECRUITING
Motivational, Affective and Performance Effects of Caffeine Supplementation nanUNKNOWN
The Effect Of Coffee And Tea Drink On Gis Functions Healing Quality After Surgery in Patients Surgery nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ADORA3 binder may also engage these)

ProteinNameSimilarity
Q28309 1.000 Q28309 →
P28647 1.000 P28647 →
Q0VC81 0.999 Q0VC81 →
Q61618 0.999 Q61618 →
P35342 0.998 P35342 →
O02667 0.996 O02667 →
P49892 0.986 P49892 →
Q60612 0.981 Q60612 →
P25099 0.975 P25099 →
P47745 0.974 P47745 →
P28190 0.972 P28190 →
P34970 0.972 P34970 →
Q5RF57 0.971 Q5RF57 →
ADORA1 Adenosine receptor A1 0.967 landscape →
P79945 0.966 P79945 →
Q923X9 0.964 Q923X9 →
O13076 0.964 O13076 →
Q5QD12 0.963 Q5QD12 →
Q96RI9 0.963 Q96RI9 →
Q9DDK4 0.963 Q9DDK4 →
Q5QD10 0.961 Q5QD10 →
Q6W3F4 0.961 Q6W3F4 →
Q923Y0 0.961 Q923Y0 →
Q969N4 0.961 Q969N4 →
Q5W8W0 0.961 Q5W8W0 →
Q5QD06 0.960 Q5QD06 →
O02835 0.960 O02835 →
P35382 0.960 P35382 →
P11616 0.960 P11616 →
Q56H79 0.960 Q56H79 →